Nymox Pharmaceutical Corporation will sponsor the Third Manhattan Alzheimer Disease Conference in New York on November 28, 2001. It was rescheduled after the September 11 disaster at the World Trade Center. As at the earlier Manhattan Conferences, the 2001 Conference will have significant new research advances made public for the first time. The Conference will have a special focus on the medical, social and ethical ramifications of the new emerging diagnostics, in particular in the area of ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.